Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
December 01, 2023
From CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
November 30, 2023
From CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
November 27, 2023
From CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
November 13, 2023
From CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
November 13, 2023
From CNBC.com News
5 things to know before the stock market opens Monday
November 13, 2023
From CNBC.com News
From CNBC.com News
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
November 10, 2023
From CNBC.com News
Cramer's Lightning Round: Buy AutoZone
November 09, 2023
From CNBC.com News
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
November 08, 2023
From CNBC.com News
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
November 02, 2023
From CNBC.com News
From CNBC.com News
Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says
November 02, 2023
From CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
November 02, 2023
From CNBC.com News
From CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
October 24, 2023
From CNBC.com News
CNBC Daily Open: Oil deals ahead of Big Tech earnings
October 24, 2023
From CNBC.com News
CNBC Daily Open: Oil deals and awaiting tech earnings
October 23, 2023
From CNBC.com News
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
October 23, 2023
From CNBC.com News
From CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
October 14, 2023
From CNBC.com News
Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic
October 13, 2023
From CNBC.com News
Tempest Therapeutics, Microsoft, Birkenstock, Novo Nordisk, Tesla: Why These 5 Stocks Are On Investors' Radars Today
October 11, 2023
From Benzinga
How is the rise of GLP-1 weight loss drugs affecting market action? Jim Cramer explains
October 11, 2023
From CNBC.com News
Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more
October 11, 2023
From CNBC.com News
Stocks making the biggest moves premarket: Plug Power, Exxon Mobil, Pioneer, Novo Nordisk and more
October 11, 2023
From CNBC.com News
From CNBC.com News
Tickers
CEO
From CNBC.com News
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.